Putting results of a clinical trial into perspective

Nicholas R Wilcken, Val J Gebski, Rhana Pike and Anthony C Keech
Med J Aust 2007; 186 (7): . || doi: 10.5694/j.1326-5377.2007.tb00942.x
Published online: 2 April 2007

Authors of articles reporting clinical trials should discuss the results of their trial in the context of existing evidence. This approach is encouraged by the CONSORT statement (Box 1).1 A trial’s contribution to the evidence can be pinpointed by seeking answers to questions such as:

  • NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW.


Competing interests:

None identified.

  • 1. Altman DG, Schulz KF, Moher D, et al, for the CONSORT Group. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001; 134: 663-694.
  • 2. Evans A, Kalra L. Are the results of randomized controlled trials on anticoagulation in patients with atrial fibrillation generalizable to clinical practice? Arch Intern Med 2001; 161: 1443-1447.
  • 3. WHI Investigators. Risks and benefits of estrogen and progestin in healthy postmenopausal women. JAMA 2002; 288: 321-333.
  • 4. HRT: what are women (and their doctors) to do [editorial]? Lancet 2004; 346: 2069-2070.
  • 5. Early Breast Cancer Trialists’ Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 1998; 351: 1451-1467.
  • 6. Gebski V, Lagleva M, Keech A, et al. Survival effects of postmastectomy adjuvant radiation therapy using biologically equivalent doses: a clinical perspective. J Natl Cancer Inst 2006; 98: 26-38.
  • 7. Cholesterol Treatment Trialists’ (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins. Lancet 2005; 366: 1267-1278.
  • 8. Keech A, Colquhoun D, Best J, et al, for the LIPID Study Group. Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial. Diabetes Care 2003; 26: 2713-2721.
  • 9. Hague W, Forder P, Simes J, et al; LIPID Investigators. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study. Am Heart J 2003; 145: 643-651.
  • 10. Charles DHM, Ness AR, Campbell D, et al. Folic acid supplements in pregnancy and birth outcome: re-analysis of a large randomised controlled trial and update of Cochrane review. Paediatr Perinat Epidemiol 2005; 19: 112-124.
  • 11. Breast International Group (BIG) 1-98 Collaborative Group. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. N Engl J Med 2005; 353: 2747-2757.
  • 12. Simes RJ, Coates AS. Patient preferences for adjuvant chemotherapy of early breast cancer: how much benefit is needed? J Natl Cancer Inst Monogr 2001; 30: 146-152.
  • 13. Seale JP, Gebski VJ, Keech AC. Generalising the results of trials to clinical practice. Med J Aust 2004; 181: 558-560. <MJA full text>


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.